rpv

What rpv does

rpv is an early-stage deep tech venture fund, operating its 2023 vintage, that invests in founders commercializing breakthrough scientific research. The fund targets five stated verticals: Neuroscience, Manufacturing, Hardware, Medical Devices, and Energy, and reports investments in 38 portfolio companies spanning areas as diverse as brain-computer interfaces (BIOS), blood substitutes (ReBlood), solid oxide fuel cells (Serenity Power), carbon nanotube semiconductors (Sixline Semiconductors), symbolic AI (Symbolic Mind), bio-computation (Intactis), 3D-printed construction (Verustruct), and muon tomography (ORE). rpv is led by Founder and General Partner Arkady Kulik (3x founder, INSEAD MBA, MSc in Physics) and supported by a venture partner bench with backgrounds at INSEAD, Wharton, Google, Microsoft, Nike, Barclays, Citi, and 500 Startups, plus a dedicated Head of AI lab. The website states the fund is "fully deployed."

The fund's core product is capital, connections, and expertise delivered to deep tech founders; it does not develop proprietary technology of its own. Revenue is generated through the standard venture capital mechanism of management fees on committed capital and carried interest on portfolio exits, though no exits, AUM, or fund size are disclosed. The fund's go-to-market is direct outbound sourcing through its team and advisor network, supplemented by inbound applications via its website (rpv.global). Portfolio company customer relationships (e.g., BIOS with Mayo Clinic, Mesomat with UPS and Yokohama, Launchpad with Yamaha and Lockheed Martin) are typically developed by the founders, with rpv facilitating introductions.

rpv is privately held and headquartered in Kirkland, United States, with 11-50 employees and a global portfolio footprint spanning North America, Europe, and Israel-aligned founders. Disclosed direct investment activity is small in dollar terms: $100K into Intactis Bio (September 2025), participation in a $1.16M CAD pre-seed for Serenity Power (April 2026), and a first equity investment into MALCOVA in 2024. The combination of a 2023 vintage, a "fully deployed" status, an 11-50 person team, and a 38-company portfolio is most consistent with a small-to-mid sized early-stage deep tech fund, though AUM and LP composition are not disclosed.

Name

rpv

Legal name

rpv

Website

https://rpv.global/

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

rpv is a 2023-vintage early-stage deep tech venture fund that has invested in 38 founders across Neuroscience, Manufacturing, Hardware, Medical Devices, and Energy, providing capital, connections, and expertise from a team drawn from INSEAD, Wharton, Google, Microsoft, and 500 Startups.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Corporate Deep Tech / R&D Commercialization CVC (FSANAHAL)

Keywords

• Early stage venture capital
• Deep tech investments
• Scientific commercialization funding
• Seed stage investing
• Venture capital management

Headquarters

HQ city

Kirkland

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Venture Fund Returns: rpv generates returns through equity investments in early-stage deep tech startups. The fund earns returns through carried interest and management fees typical of venture capital structures. Returns are realized through portfolio company exits via acquisitions or IPOs.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

rpv is a 2023 deep tech venture fund that provides early-stage equity capital, strategic connections, and operational expertise to 38 founders commercializing breakthrough scientific research. Investments span five verticals—Neuroscience, Manufacturing, Hardware, Medical Devices, and Energy—with typical venture capital returns realized through management fees and carried interest from portfolio company exits.

Product overview

rpv is a 2023 deep tech venture fund that functions as an investment platform focused on early-stage ventures. The fund is fully deployed and has invested in 38 founders commercializing breakthrough scientific research. Rather than offering a single unified product, rpv's offering consists of venture capital investment and support services (capital, connections, and expertise) deployed across a portfolio of portfolio companies. The portfolio spans multiple deep tech verticals including Neuroscience (Sanmai, BIOS, Brainflow, Neuraworx, Craniosense), Manufacturing & Materials (Tetmet, Studio 3e8, Nanoplume, FAST metals, Deep Root Biolabs), Hardware & Semiconductors (Sixline Semiconductors, K1 Semiconductor), Medical Devices (Fareon, Malcova, Mimic, Laminar, Vertility, Reblood), Energy (Serenity Power, Intrinsic Power, PhotonVault), AI/ML (Symbolic Mind, Intactis, Icarus), Robotics (Paradigm Robotics, Amaru Robotics), and Other Deep Tech (Launchpad, Viewmind, AirTulip, Mesomat, ORE, Arinna, Segura, Ekion, Verustruct, Surf Therapeutics). The fund's value proposition is built on rigorous scientific method and strong ethical standards.

Differentiator

Problem solved

Functional benefit

Products and services

• rpv Deep Tech Venture Fund 2023-vintage early-stage deep tech venture fund that provides equity capital, strategic connections, and operational expertise to founders commercializing breakthrough scientific research in Neuroscience, Manufacturing, Hardware, Medical Devices, and Energy. The fund has invested in 38 founders.

Quantifiable outcome

• 38 founders invested and supported with capital, connections, and expertise

Named customers38 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• Exergy SolutionscoreTechnology or Integration · 27 April 2026Serenity Power, a portfolio company of rpv, partnered with Exergy Solutions for system development targeting pilot deployments with a client in Italy and another in Alberta. Exergy Solutions provides technical expertise for developing solid oxide fuel cell systems.
• Mayo CliniccoreStrategic or Co-development PartnerBIOS, an rpv portfolio company, has secured a partnership with Mayo Clinic. BIOS is building a universal neuro-electronic connector that enables two-way feedback for prosthetics with signal latency of less than 30ms and has received Breakthrough Device Designation.
• Launchpad Clients (Yamaha, Lockheed Martin)minorChannel Partner/ Reseller/ DistributorLaunchpad, an rpv portfolio company, serves clients including Yamaha and Lockheed Martin. Launchpad is led by Yoav Zingher, an accomplished entrepreneur with a successful exit.
• UPS and Yokohama (Pilot Programs)minorStrategic or Co-development PartnerMesomat, an rpv portfolio company, has proven demand through pilot programs with UPS and Yokohama. Mesomat has developed real-time sensors that measure road grip, tire wear, pressure, and temperature, saving an average of $2,000 per year per vehicle.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Lux Capital: Lux Capital is a leading deep tech venture firm investing early-stage capital in breakthrough science and engineering (including neuroscience, advanced materials, energy, and semiconductors). It is one of the most direct comparables to rpv in deep tech thesis, stage focus, and value-add model.
• Anzu Partners: Anzu Partners is a venture capital firm that invests exclusively in deep tech, including industrial, medical, and clean energy technologies. It is a strong comparable in deep tech focus, early-stage check size, and the value-add support model rpv follows.
• Engine Ventures: Engine Ventures (formerly The Engine, spun out of MIT) invests in Tough Tech founders commercializing breakthrough science across climate, advanced materials, and compute. Its MIT-aligned network and deep tech thesis make it a direct peer to rpv.
• Prime Movers Lab: Prime Movers Lab invests globally in early-stage breakthrough scientific inventions across energy, transportation, infrastructure, manufacturing, and human augmentation. It is one of the closest thematic matches to rpv's deep tech, science-driven, multi-vertical early-stage strategy.
• DCVC (Data Collective): DCVC is an early-stage deep tech venture firm backing founders applying deep science to solve big problems in compute, energy, materials, and life sciences. It is highly comparable in stage, thesis, and the scientist-founder orientation that rpv also pursues.
• Breakthrough Energy Ventures: Founded by Bill Gates, BEV invests early-stage capital in companies developing breakthrough clean energy technologies. Its focus on deep tech commercialization and scientific rigor aligns closely with rpv's energy vertical and overall methodology.
• Material Impact: Material Impact is a deep tech venture fund focused on early-stage companies developing transformative materials science innovations. It is comparable to rpv's manufacturing and materials vertical, particularly for portfolio companies like Tetmet, Studio 3e8, and Nanoplume.

Broad incumbents

• Obvious Ventures: Obvious Ventures is a mission-driven venture firm investing in purpose-driven founders across health, sustainability, and economic empowerment. Its mission-aligned thesis and multi-vertical approach overlap with rpv's well-being framing, though it is broader in sector scope.
• Khosla Ventures: Khosla Ventures is one of the largest early-stage deep tech investors with broad exposure to science-driven ventures across energy, biotech, AI, and materials. It is a broader incumbent that overlaps with rpv's deep tech, early-stage orientation but at much larger fund scale.
• Founders Fund: Founders Fund is an early-stage venture firm with a stated focus on frontier science and technology investments. It overlaps with rpv in deep tech and contrarian science bets, but operates at substantially greater fund scale and brand recognition.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles16 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments9 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about rpv